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PT02.13
Protein profiling of extracellular vesicles from the oviductal fluid of
sows before and after ovulation
Inga Weiss; Sergio E. Palma-Vera; Andreas Vernunft; Jennifer Schoen;
Shuai Chen
Institute of Reproductive Biology, Leibniz Institute for Farm Animal Biology
(FBN), Dummerstorf, Germany, Dummerstorf, Germany
Background: Extracellular vesicles (EV) present in the oviduct fluid
(OF) have been suggested to deliver oviductal signals to gametes/
embryo, thereby mediating the gamete/embryo–maternal crosstalk.
Aim of this pilot study was to characterize the protein profile of ovi-
ductal EVs collected from sows before and after ovulation.
Methods: We isolated EVs from OF collected from sows in mid and late
estrus (n = 2/group) and in metestrus (d2 post ovulation, n = 4), using a
two-step polyethylene glycol precipitation followed by ultracentrifuga-
tion. EVs were visualized by transmission electron microscopy (TEM).
BCA assay and mass spectrometry were performed to analyse their
protein content. Differential protein expression analysis was performed
using the R/Bioconductor package “Differential Enrichment analysis of
Proteomics data” (DEP).
Results: TEM proved the presence of EVs (cup-shaped structure and
size smaller than 150 nm) after isolation. Mass spectrometry analysis
identified 1002 proteins which were expressed in all samples. The top
500 variable proteins produced cycle stage-dependent clusters after
principal component analysis, which was corroborated by hierarchical
clustering analysis of the differentially expressed proteins (5% FDR).
Due to the low number of biological replicates, we observed a small
number of differentially expressed proteins. The comparison between
late-estrus (around LH peak) and metestrus showed eight up-regulated
and three downregulated proteins, while the comparison between mid-
estrus (before LH peak) and metestrus indicated six upregulated and six
downregulated proteins. Seven significantly up-regulated proteins were
detected when comparing the two estrus stages. Interestingly, upregu-
lated proteins of the contrasts late-estrus versus mid-estrus and late-
estrus versus metestrus intersected in six common proteins CRYM,
RHOA, SP17, RS20, AKAP9 and ELMO3. In comparison to both other
stages, HEM2 was upregulated in metestrus.
Summary/conclusion: These first results indicate that the protein con-
tent of oviductal EVs is dynamically adapted during the periovulatory
period. These regulated EV proteins are potentially involved in gamete/
embryo–maternal interactions.
Funding: Inga Weiss is supported by the H. Wilhelm Schaumann
Foundation, Hamburg, Germany.
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Treatment with intravenous immunoglobulin increases the level of
small EVs in plasma of pregnant women with recurrent spontaneous
abortions
Rikke Baek1; Malene M. Jørgensen1; Kim Varming1; Ole Bjarne Christiansen2
1Department of Clinical Immunology, Aalborg University Hospital, Aalborg,
Denmark; 3Department of Obstetrics and Gynecology, Aalborg University
Hospital, Aalborg, Denmark
Background: Recurrent spontaneous abortion (RSA) is the cause of
childlessness in 2–5% of reproducing couples. Immunological
mechanisms have been proposed as an aetiology in some cases of
RSA. Various forms of immunotherapy have been attempted in
individuals thought to have an immunologic mechanism associated
with RSA. Intravenous immunoglobulin has been tested in a pla-
cebo-controlled trial of women with RSA, and the effect of plasma
small EV (sEV) phenotypes and levels were investigated during the
pregnancy.
Methods: Twelve pregnant women with RSA who participated in the
aforementioned trial were included in this study. In a blinded set-up,
five of the women were given treatment with intravenous immunoglo-
bulin and the rest were given placebo (human albumin). Venous per-
ipheral blood (EDTA) was obtained from the women at several time
points during their pregnancy.
Small EV concentration and composition were analysed by the EV Array
(Jørgensen et al., 2013, JEV) using 29 selected surface markers. The
antibodies used to capture the EVs included antibodies against EVs in
general (CD9, CD63, CD81, Alix, Flotilin-1 etc.) and placental and
immunological markers (PLAP, HLA ABC, HLA DR/DP/DQ, HLA
G, FSHR, LHR, TSHR etc.).
Results: The first of the sequential samples (obtained before the first
infusion in pregnancy week 5) from each woman were used as reference
point to which the rest of the samples were normalized in order to detect
the change over time. Already at the second sampling point (after 11–21
days), the level of sEVs carrying CD9 and CD81 increased massively (2–
4 fold). After 30–40 days, this increase stops and remains stable during
the rest of the pregnancy.
Summary/conclusion: A larger cohort/study is needed for increasing the
statistical power. However, the tendencies are notably that the treatment
with intravenous immunoglobulin has an effect on the level of sEVs in
plasma.
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The role of extracellular vesicles in mediating placental responses to
maternal cellular stress
Catherine Evans; Thomas Rice; Beate Kampmann; Beth Holder
IMPERIAL COLLEGE LONDON, London, United Kingdom
Background: During pregnancy, the placenta acts as the interface
between the maternal and foetal circulations. The placenta sheds extra-
cellular vesicles (EVs), including exosomes, into the maternal circula-
tion, which interact with maternal immune cells. We have recently
demonstrated that this trafficking of EVs is bidirectional, with trafficking
of EVs from immune cells to the placenta. EVs shed by stressed cells can
elicit a “bystander effect” in recipient cells. We therefore investigated the
functional impact of EVs released by stressed monocytes on placental
trophoblast cells.
Methods: THP-1 cells were exposed to oxidative stress by hydrogen
peroxide treatment. EVs were isolated by differential centrifugation
and characterized by nanosight tracking analysis. EVs were added to
BeWo trophoblast cells, which were then either left unstressed, or were
subjected to oxidative stress.
Results: Oxidative stress induced by hydrogen peroxide had no effect on
EV size nor concentration. Pretreatment with EVs from stressed or
unstressed cells caused a small reverse in reduction of trophoblast
viability in response to oxidative stress.
Summary/conclusion: EVs from maternal immune cells may help
increase placental resistance to oxidative stress.
Funding: NIHR Imperial Biomedical Research Centre
MRC The Gambia
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